GASTRICHIP: D2 resection and hyperthermic intraperitoneal chemotherapy in locally advanced gastric carcinoma: a randomized and multicenter phase III study

Lack of prognostic significance of conventional peritoneal cytology in colorectal and gastric cancers: Results of EVOCAPE 2 multicentre prospective study

(2013) E. Cotte et al.   EJSO

The Impact of Perioperative Chemotherapy on Survival in Patients With Gastric Signet Ring Cell Adenocarcinoma

(2011) Mathieu Messager et al.   ANNALS OF SURGERY

Meta-Analysis of D1 Versus D2 Gastrectomy for Gastric Adenocarcinoma

(2011) Muhammed Ashraf Memon et al.   ANNALS OF SURGERY

Dissemination of Free Cancer Cells from the Gastric Lumen and from Perigastric Lymphovascular Pedicles during Radical Gastric Cancer Surgery

(2011) Tae-Su Han et al.   ANNALS OF SURGICAL ONCOLOGY

Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Improves Survival of Patients with Peritoneal Carcinomatosis from Gastric Cancer: Final Results of a Phase III Randomized Clinical Trial

(2011) Xiao-Jun Yang et al.   ANNALS OF SURGICAL ONCOLOGY

SAE: An R package for early stopping rules in clinical trials

(2011) C. Bascoul-Mollevi et al.   COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE

Perioperative Chemotherapy Compared With Surgery Alone for Resectable Gastroesophageal Adenocarcinoma: An FNCLCC and FFCD Multicenter Phase III Trial

(2011) Marc Ychou et al.   JOURNAL OF CLINICAL ONCOLOGY

Peritoneal Carcinomatosis from Gastric Cancer: A Multi-Institutional Study of 159 Patients Treated by Cytoreductive Surgery Combined with Perioperative Intraperitoneal Chemotherapy

(2010) Olivier Glehen et al.   ANNALS OF SURGICAL ONCOLOGY

Toward curative treatment of peritoneal carcinomatosis from nonovarian origin by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy

(2010) Olivier Glehen et al.   CANCER

Benefit of Adjuvant Chemotherapy for Resectable Gastric Cancer

(2010)   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Epirubicin, Oxaliplatin, and Capecitabine With or Without Panitumumab for Advanced Esophagogastric Cancer: Dose-Finding Study for the Prospective Multicenter, Randomized, Phase II/III REAL-3 Trial

(2010) Alicia F.C. Okines et al.   JOURNAL OF CLINICAL ONCOLOGY

Prognostic value of HMGB1 overexpression in resectable gastric adenocarcinomas

(2010) Guoqiang Bao et al.   World Journal of Surgical Oncology

Signet Ring Cell Histology is an Independent Predictor of Poor Prognosis in Gastric Adenocarcinoma Regardless of Tumoral Clinical Presentation

(2009) Guillaume Piessen et al.   ANNALS OF SURGERY

Positive Peritoneal Washing Cytology in Multiple Cavities Can Predict Poor Prognosis of Advanced Gastric Cancer Patients

(2009) Yoichiro Homma et al.   ANNALS OF SURGICAL ONCOLOGY

Prognostic Factors for Local Control After Breast Conservation: Does Margin Status Still Matter?

(2009) Shannon MacDonald et al.   JOURNAL OF CLINICAL ONCOLOGY

Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Malignant Peritoneal Mesothelioma: Multi-Institutional Experience

(2009) Tristan D. Yan et al.   JOURNAL OF CLINICAL ONCOLOGY

Peritoneal Colorectal Carcinomatosis Treated With Surgery and Perioperative Intraperitoneal Chemotherapy: Retrospective Analysis of 523 Patients From a Multicentric French Study

(2009) Dominique Elias et al.   JOURNAL OF CLINICAL ONCOLOGY

Capecitabine and Oxaliplatin for Advanced Esophagogastric Cancer

(2008) David Cunningham et al.   NEW ENGLAND JOURNAL OF MEDICINE